Intraprostatic botulinum toxin type “A” injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation-Reference-Cited by-同舟云学术

Intraprostatic botulinum toxin type “A” injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation

Published:2017-08-25 Issue:3 Volume:37 Page:1031-1038
ISSN:0733-2467
Container-title:Neurourology and Urodynamics
language:en
Short-container-title:Neurourology and Urodynamics

Author:

Totaro Angelo¹,Pinto Francesco¹,Pugliese Dario¹^ORCID,Vittori Matteo¹,Racioppi Marco¹,Foschi Nazario¹,Bassi Pier Francesco¹,Sacco Emilio¹^ORCID

Affiliation:

1. Department of Urology, Medical School; Catholic University of Sacred Heart; Rome Italy

Publisher

Wiley

Subject

Urology,Clinical Neurology

Reference28 articles.

1. Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners;Roehrborn;Prost Canc Prost Dis,2006

2. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines);Madersbacher;Eur Urol,2004

3. The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia;Lepor;Rev Urol,2006

4. Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options;Sandhu;Drugs Aging,2005

5. Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population;Deliveliotis;Urol Res,2004

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?;Toxins;2022-07-18

2. What is the role of minimally invasive surgical treatments for benign prostatic enlargement?;BMJ;2022-05-25

3. Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study;Arab Journal of Urology;2019-10-02

4. Managing urinary incontinence in women - a review of new and emerging pharmacotherapy;Expert Opinion on Pharmacotherapy;2018-10-10

5. Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction;Toxins;2018-06-26